Azithromycin for Oral Suspension

DRUG3 trials

Sponsors

University of California, San Francisco

Conditions

Antimicrobial ResistanceChild HealthImplementationMoralityMortalityResistance Bacterial

Phase 4

Azithromycin for Child Survival in Niger: Delivery Trial

CompletedNCT04774991

University of California, San FranciscoChild Health, Implementation, Mortality

Start: 2021-06-28End: 2023-06-30Updated: 2025-04-24

Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)

TerminatedNCT05288023

University of California, San FranciscoChild Health, Implementation, Morality +1

Start: 2022-12-01End: 2024-01-15Updated: 2025-03-28

Azithromycin for Child Survival in Niger II

RecruitingNCT06358872

University of California, San FranciscoAntimicrobial Resistance, Mortality

Start: 2024-04-29End: 2028-04-29Target: 3300000Updated: 2026-08-17

Related Papers

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions

Trials2026-02-18

Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial

PLOS Global Public Health2023-11-152 citations